ARDX

Ardelyx
ARDX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.30B
EV
$1.23B
Shares Outstanding
238.36M
Beta
0.81

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$10.75
P/E 2025E
-
P/Revenue 2025E
3.46x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Ardelyx, Inc.

gainify
ARDX

Ardelyx, Inc.

ARDX

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company’s lead product candidate is tenapanor for the treatment of p...

Sector

Healthcare

Industry

Biotechnology

CEO

Raab, Michael

Employees

395

IPO Date

2014-06-19

Headquarters

400 Fifth Avenue, Suite 210, Waltham, Massachusetts, 02451, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved